SAN DIEGO, Jan. 7, 2026 /PRNewswire/ — Rakuten Medical, Inc., a global biotechnology company developing and commercializing its proprietary Alluminox® platform-based photoimmunotherapy, today announced the closing of a $100 million Series F financing round. This includes $70 million in…
Rakuten Medical has raised $119,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Mickey Mikitani played a key role in securing the recent investment and it will aid in…
According to filings with the U.S. Securities and Exchange Commission, Rakuten Medical is raising $123,689,146.00 in new funding. Sources indicate that as part of senior management President, Takashi Toraishi played a key role in securing…
San Mateo, CA – According to filings with the U.S. Securities and Exchange Commission, Rakuten Medical is raising $291,010,708.00 in new funding. Sources indicate as part of senior management President, Takashi Toraishi played a key…
San Mateo, CA – According to filings with the U.S. Securities and Exchange Commission, Rakuten Medical Inc. is raising $100 Million in a new round of investment. Sources indicate as part of senior management President,…